Although Cervarix looks to be a hit, Merck’s Gardasil launched in 2006 will have had almost a year and a half to gain market share before the new competitor arises. At that point, Gardasil will have been a “tried and true” product, making entry more difficult for Cevarix.
GSK settles more lawsuits but will face a courtdate in Oct. that could be cost the greedy British drugmaker millions of dollars. GSK has recently been cited for treating its sales force like a mafia kingpin hiring former FBI and New York City police detectives to investigate their own people to get them fired for charges that the company itself ordered their rep's to do. These ruthless tactics will eventually cost the them huge sales as they lose credability with Doctors.